Gilead Files To Break Tamiflu Agreement With Roche, Citing Breach Of Contract

Roche will have a chance to address Gilead's claims before their partnership for the flu antiviral is terminated. Gilead claims Roche breached the contract by lessening its marketing efforts, neglecting manufacturing quality management, and inaccurately calculating royalty payments.